[Huntington's disease, towards the end of neuronal death?].
Véronique
V
Girault
D016923:Cell Death / Q000187:drug effects* / Q000235:genetics; D005799:Genes, Dominant / Q000235:genetics; D006801:Humans; D006816:Huntington Disease / Q000235:genetics / Q000473:pathology / Q000517:prevention & control*; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use*; D009154:Mutation / Q000235:genetics; D009369:Neoplasms / Q000517:prevention & control; D009410:Nerve Degeneration / Q000235:genetics / Q000473:pathology / Q000517:prevention & control*; D019636:Neurodegenerative Diseases / Q000517:prevention & control; D017346:Protein Serine-Threonine Kinases; D011518:Proto-Oncogene Proteins / Q000627:therapeutic use*; D051057:Proto-Oncogene Proteins c-akt; D012307:Risk Factors
D011518:Proto-Oncogene Proteins; D007334:Insulin-Like Growth Factor I; D017346:Protein Serine-Threonine Kinases; D051057:Proto-Oncogene Proteins c-akt